SCHEMBL887214

SCHEMBL887214

O=CC1CCCCC(C=O)CCC(C=O)CCC1

nearest known ligand 0.81

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ADH1A P07327 14/20 0.41
ADH1C P00326 11/20 0.41
ADH4 P08319 3/20 0.39
ADH1B P00325 5/20 0.35
ADH7 P40394 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3691070 0.97 ADH1A (0.38) ADH1AADH1CADH4ADH1BADH7
SCHEMBL1684061 0.97 ADH1A (0.36) ADH1AADH1CADH4ADH1BADH7
SCHEMBL1684060 0.97 ADH1A (0.36) ADH1AADH1CADH4ADH1BADH7
SCHEMBL1684081 0.97 ADH1A (0.36) ADH1AADH1CADH4ADH1BADH7
SCHEMBL1684079 0.97 ADH1A (0.36) ADH1AADH1CADH4ADH1BADH7
SCHEMBL20573718 0.93 ADH1A (0.43) ADH1AADH1CADH4ADH1BADH7
SCHEMBL7533798 0.93 ADH1A (0.39) ADH1AADH1CADH4ADH1BADH7
Cyclopentanecarbaldehyde SCHEMBL26171 0.93
SCHEMBL1684041 0.93 ADH1A (0.40) ADH1AADH1CADH4ADH1BADH7
SCHEMBL1684040 0.93 ADH1A (0.40) ADH1AADH1CADH4ADH1BADH7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378434-B2 Curable coating compositions EASTMAN CHEMICAL COMPANY (US) 2025-08-05 US claimed
EP-3894477-B1 CONTROLLED CURE FOR COMPOSITIONS COMPRISING ACETOACETYLATED RESINS EASTMAN CHEM CO (US) 2025-01-15 EP claimed
EP-3894475-B1 ASSEMBLY COMPONENTS COMPRISING CURABLE COMPOSITIONS CONTAINING ACETOACETYLATED RESINS EASTMAN CHEM CO (US) 2024-06-19 EP claimed
CN-113166033-B Curable coating composition 伊士曼化工公司 2024-05-24 CN claimed
EP-3894386-B1 CURABLE COATING COMPOSITIONS EASTMAN CHEM CO (US) 2024-02-21 EP claimed
US-11820923-B2 Controlled cure for compositions comprising acetoacetylated resins EASTMAN CHEMICAL COMPANY (US) 2023-11-21 US claimed
EP-3894474-B1 CURABLE COMPOSITIONS COMPRISING ACETOACETYLATED RESINS, ALDEHYDES AND CERTAIN AMINES EASTMAN CHEM CO (US) 2023-09-13 EP claimed
US-11732165-B2 Low-temperature curable compositions EASTMAN CHEMICAL COMPANY (US) 2023-08-22 US claimed
CN-113195632-B Controlled curing of compositions comprising acetoacetylated resins 伊士曼化工公司 2023-07-14 CN claimed
US-11530342-B2 Curable compositions comprising acetoacetylated resins, aldehydes and certain amines EASTMAN CHEMICAL COMPANY (US) 2022-12-20 US claimed
US-20200181446-A1 FLEXIBLE SUBSTRATES COMPRISING CURABLE COMPOSITIONS CONTAINING ACETOACETYLATED RESINS EASTMAN CHEMICAL COMPANY (US) 2020-06-11 US claimed
US-20200181312-A1 ASSEMBLY COMPONENTS COMPRISING CURABLE COMPOSITIONS CONTAINING ACETOACETYLATED RESINS EASTMAN CHEMICAL COMPANY (US) 2020-06-11 US claimed
US-20200181324-A1 CONTROLLED CURE FOR COMPOSITIONS COMPRISING ACETOACETYLATED RESINS EASTMAN CHEMICAL COMPANY (US) 2020-06-11 US claimed
US-20200181465-A1 CURABLE ACETOACETYLATED RESIN COMPOSITIONS COMPRISING ALDEHYDES AND CERTAIN BASIC CATALYSTS EASTMAN CHEMICAL COMPANY (US) 2020-06-11 US claimed
EP-3638706-A1 LOW-TEMPERATURE CURABLE COMPOSITIONS Eastman Chemical Company (US) 2020-04-22 EP claimed
US-20200109321-A1 LOW-TEMPERATURE CURABLE COMPOSITIONS EASTMAN CHEMICAL COMPANY (US) 2020-04-09 US claimed
US-10563040-B2 Low-temperature curable compositions EASTMAN CHEMICAL COMPANY (US) 2020-02-18 US claimed
WO-2019142208-A1 AMBIENT TEMPERATURE CURABLE NON-ISOCYANATE POLYHYDROXYALKYLURETHANE MOIETIES WITH ALDEHYDE CROSS LINKER Asian Paints Ltd. (IN) 2019-07-25 WO claimed
WO-2018231601-A1 LOW-TEMPERATURE CURABLE COMPOSITIONS EASTMAN CHEMICAL COMPANY (US) 2018-12-20 WO claimed
US-20180355145-A1 LOW-TEMPERATURE CURABLE COMPOSITIONS EASTMAN CHEMICAL COMPANY (US) 2018-12-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10563040-B2 Low-temperature curable compositions KDM6B, KDM6A, ALDOA ADH1A 247/4885ADH1C 476/4885ADH4 1422/4885
US-20180355145-A1 LOW-TEMPERATURE CURABLE COMPOSITIONS KDM6B, KDM6A, ALDOA ADH1A 247/4885ADH1C 476/4885ADH4 1422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.